Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Potential approaches for myocardial regeneration

M H Soonpaa1, A I Daud, G Y Koh

  • 1Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis 46202-4800, USA.

Annals of the New York Academy of Sciences
|March 27, 1995
PubMed
Summary

Adult heart cells cannot regenerate, making heart damage permanent. New strategies like gene therapy or cell transplantation could increase cardiomyocyte numbers to repair diseased hearts.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pembrolizumab versus ipilimumab for advanced melanoma: 10-year follow-up of the phase III KEYNOTE-006 study.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Intratumoral delivery of tavokinogene telseplasmid yields systemic immune responses in metastatic melanoma patients.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Donor Heart Treatment With COMP-Ang1 Limits Ischemia-Reperfusion Injury and Rejection of Cardiac Allografts.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

The combination of axitinib followed by paclitaxel/carboplatin yields extended survival in advanced BRAF wild-type melanoma: results of a clinical/correlative prospective phase II clinical trial.

British journal of cancer·2015
Same author

SIRT2 regulates tumour hypoxia response by promoting HIF-1α hydroxylation.

Oncogene·2014
Same author

Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma.

British journal of cancer·2011

Area of Science:

  • Cardiovascular biology
  • Regenerative medicine
  • Cardiac physiology

Background:

  • Adult mammalian cardiomyocytes exhibit limited capacity for hyperplastic growth.
  • Loss of cardiomyocytes from injury or disease leads to irreversible cardiac damage.
  • Current treatments for end-stage heart failure primarily rely on cardiac transplantation.

Purpose of the Study:

  • To explore strategies for augmenting cardiomyocyte populations in the adult mammalian heart.
  • To investigate potential therapeutic approaches for reversing cardiomyocyte loss and improving cardiac function.

Main Methods:

  • Review of existing literature on cardiomyocyte proliferation and regeneration.
  • Analysis of potential therapeutic avenues including genetic modification and cell-based therapies.

Related Experiment Videos

  • Discussion of the feasibility of increasing cardiomyocyte number through regulatory protein expression or cell grafting.

    • Main Results:

    • Adult cardiomyocytes are terminally differentiated and lack significant proliferative potential.
    • Strategies to induce cardiomyocyte proliferation or introduce new cardiomyocytes are under investigation.
    • Augmenting cardiomyocyte number presents a potential therapeutic strategy for heart repair.

    Conclusions:

    • Regeneration of lost cardiomyocytes is a critical challenge in treating heart disease.
    • Therapeutic strategies involving cardiomyocyte number augmentation hold promise for cardiac repair.
    • Further research into myocardial regeneration and cell-based therapies is warranted.